|Date||Title|| || |
|05/10/13||Sunesis to Present at Upcoming Investor Conferences|
|SOUTH SAN FRANCISCO, Calif., May 10, 2013 (GLOBE NEWSWIRE) -- Sunesis Pharmaceuticals, Inc. (Nasdaq:SNSS) today announced that the Company will present at two upcoming investor conferences.
Dan Swisher, Chief Executive Officer of Sunesis, will present at the Bank of America Merrill Lynch Health Care Conference on Tuesday, May 14th at 3:00 PM Pacific Time at the Encore at the Wynn in Las Vegas.
Eric Bjerkholt, Executive Vice President, Corporate Development and Finance, Chief Financial Officer ... |
|05/09/13||Sunesis Pharmaceuticals Reports First Quarter Financial Results and Recent Highlights|
|Sunesis to Host Conference Call Today at 11:00AM Eastern Time
SOUTH SAN FRANCISCO, Calif., May 9, 2013 (GLOBE NEWSWIRE) -- Sunesis Pharmaceuticals, Inc. (Nasdaq:SNSS) today reported financial results for the quarter ended March 31, 2013. Loss from operations for the three months ended March 31, 2013 was $7.8 million. As of March 31, 2013, cash, cash equivalents and marketable securities totaled $61.0 million.
"We continue to make great progress with the VALOR trial, which has now enrolled 6... |
|05/02/13||Sunesis to Host Conference Call on May 9th to Discuss First Quarter Financial Results and Recent Highlights|
|SOUTH SAN FRANCISCO, Calif., May 2, 2013 (GLOBE NEWSWIRE) -- Sunesis Pharmaceuticals, Inc. (Nasdaq:SNSS) today announced that it will host a conference call on Thursday, May 9, 2013 at 11:00 a.m. Eastern Time to discuss corporate updates and financial results for the first quarter ended March 31, 2013.
The call can be accessed by dialing (877) 280-4958 (U.S. and Canada) or (857) 244-7315 (international), and entering passcode 39516372.
To access the live audio webcast, or the subsequent ... |